कृपया अन्य खोज का प्रयास करें
Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address the spectrum of diseases by deploying gene editing technology. The company offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme; and a pegRNA, which targets the Prime Editor to a specific genomic location and provides a template for making the desired edit to the target DNA sequence. It has a research collaboration with Cimeio Therapeutics to develop Prime Edited Shielded-Cell & Immunotherapy Pairs for genetic diseases, acute myeloid leukemia, and myelodysplastic syndrome. The company was incorporated in 2019 and is based in Cambridge, Massachusetts.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Anastasia Khvovora | 54 | 2022 | Member of Scientific Advisory Board |
Agnieszka Czechowicz | - | 2022 | Member of Scientific Advisory Board |
David R. Liu | - | 2022 | Co-Founder & Chair of Scientific Advisory Board |
Wendy K. Chung | 54 | 2021 | Independent Director |
Robert Taylor Nelsen | 61 | 2020 | Independent Director |
Yvonne Chen | - | 2022 | Member of Scientific Advisory Board |
Keith Michael Gottesdiener | 69 | 2020 | President, CEO, Secretary & Director |
Eric N. Olson | - | - | Member of Scientific Advisory Board |
Kaye I. Foster-Cheek | 63 | 2021 | Independent Director |
Guangping Gao | - | 2022 | Member of Scientific Advisory Board |
David P. Schenkein | 66 | 2019 | Independent Director |
James Haber | - | 2022 | Member of Scientific Advisory Board |
Samuel H. Sternberg | - | 2022 | Member of Scientific Advisory Board |
Shengdar Q. Tsai | - | 2022 | Member of Scientific Advisory Board |
Jay Shendure | - | 2022 | Member of Scientific Advisory Board |
Michael A. Kelly | 66 | 2021 | Independent Director |
Muthiah Manoharan | 70 | 2022 | Member of Scientific Advisory Board |
Ben Kleinstiver | - | 2022 | Member of Scientific Advisory Board |
Thomas J. Cahill | 36 | 2021 | Independent Director |
Jeffrey D. Marrazzo | 44 | 2023 | Director |
Gerald Schwank | - | 2023 | Member of Scientific Advisory Board |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है